Associate Director, Clinical Operations
Axsome Therapeutics Inc- Full Time
- Senior (5 to 8 years)
Candidates should possess a Master's degree with a minimum of 5 years of experience, or a Doctoral degree with a minimum of 3 years of experience. Strong scientific and strategic leadership skills are required, along with expertise in study designs, analysis approaches, and research methodology, particularly within the oncology field. The role necessitates the ability to provide expert guidance to both internal teams and clients, ensuring alignment with their needs and objectives.
As an Associate Director, the individual will lead the scientific and analytic services provided to clients, ensuring alignment with their needs and objectives, and overseeing the design and execution of observational research studies focusing on oncology research. They will provide scientific and strategic guidance on study designs, analysis approaches, and research methodology, communicate the scientific impact of evidence generation, and collaborate with cross-functional department leaders to define strategic business goals and drive informed decision-making.
Software solutions for real-world evidence analysis
Aetion develops software solutions that utilize real-world evidence (RWE) to assist life sciences companies, regulators, and purchasers in making informed decisions. Their software analyzes real-world data to provide insights into the effectiveness and safety of medical innovations, from initial hypotheses to long-term monitoring. Aetion's clients include major pharmaceutical companies and healthcare regulators, who benefit from the ability to generate and analyze diverse data sets for clinical insights that were previously hard to obtain. The company differentiates itself by offering a platform that not only manages longitudinal data but also generates synthetic health data using artificial intelligence. Aetion's goal is to maximize the return on investment for its clients by providing rapid insights that facilitate critical decision-making, ultimately expediting patient care and treatment options.